Mesenchymal stem cells (MSC) are being widely studied for their potential in tissue engineering and regenerative medicine. However, recent evidence suggests that the beneficial effects
epigenome shows all the information related to the expression of genes that are not found in the DNA sequence but rather the result of a
regenerative medicine based transplants obtained from donors or mesenchymal stem cells of the fetus and newborn, important obstacles such as limited availability of organs, ethical
Background: Mesenchymal stem cell-based treatments are now emerging as a therapy for corneal epithelial damage. Although the bone marrow, adipose tissue and umbilical cord blood